Thaci, D., Papp, K., Gordon, K., Morita, A., Gooderham, M., Foley, P., Alemano, E., Kisa, R., Elbez, Y., Ren, H., & Banerjee, S. (2019). An oral, selective tyrosine kinase 2 inhibitor, BMS-986165, improves quality of life in psoriasis: results from a Phase 2 study. SKIN The Journal of Cutaneous Medicine, 3, S12.